It demonstrated that intravenous administration of T. cruzi-derived neurotrophic factors in MyD88-knockout mice (deficient in TLR signaling) increased CX3CL1 and CCL2 levels, modulating inflammatory responses mediated by Trk signaling and reducing cardiac fibrosis (11). This evidence concerns the gene CCL2 and fibrosis.